Ra Capital Management, Llc
Affiliations
- Director at Ars Pharmaceuticals Inc. (SPRY), 2023-08-31
- Large Shareholder at An2 Therapeutics Inc. (ANTX), 2023-08-22
- Large Shareholder, Director at Wave Life Sciences Ltd. (WVE), 2023-08-10
- Other at Dice Therapeutics Inc. (DICE), 2023-08-09
- Large Shareholder, Director at Acumen Pharmaceuticals Inc. (ABOS), 2023-07-25
- Large Shareholder, Director at Janux Therapeutics Inc. (JANX), 2023-07-21
- Director at Black Diamond Therapeutics Inc. (BDTX), 2023-07-07
- Large Shareholder, Director at Werewolf Therapeutics Inc. (HOWL), 2023-06-23
- Other at Satsuma Pharmaceuticals Inc. (STSA), 2023-06-13
- Large Shareholder, Director at Nkarta Inc. (NKTX), 2023-06-09
- Large Shareholder, Director at Aerovate Therapeutics Inc. (AVTE), 2023-06-08
- Large Shareholder, Director at Solid Biosciences Inc. (SLDB), 2023-06-08
- Large Shareholder, Director at Icosavax Inc. (ICVX), 2023-06-08
- Large Shareholder, Director at Vor Biopharma Inc. (VOR), 2023-06-02
- Large Shareholder, Director at Tyra Biosciences Inc. (TYRA), 2023-06-02
- Large Shareholder, Director at Eliem Therapeutics Inc. (ELYM), 2023-05-22
- Large Shareholder, Director at 89Bio Inc. (ETNB), 2023-03-30
- Other at Enliven Therapeutics Inc. (ELVN), 2023-02-27
- Director at Mineralys Therapeutics Inc. (MLYS), 2023-02-16
- Large Shareholder at Fulcrum Therapeutics Inc. (FULC), 2023-01-24
- Large Shareholder, Director at Acrivon Therapeutics Inc. (ACRV), 2022-11-21
- Large Shareholder, Director at Forma Therapeutics Holdings Inc. (FMTX), 2022-10-14
- Large Shareholder, Director at Iteos Therapeutics Inc. (ITOS), 2022-06-11
- Large Shareholder at Kala Pharmaceuticals Inc. (KALA), 2022-05-26
- Large Shareholder, Director at Pepgen Inc. (PEPG), 2022-05-12
- Large Shareholder, Director at Cytek Biosciences Inc. (CTKB), 2022-03-16
- Large Shareholder at Rxsight Inc. (RXST), 2021-08-13
- Director at Therapeutics Acquisition Corp. (RACA), 2021-06-24
- Large Shareholder at Scpharmaceuticals Inc. (SCPH), 2021-03-16
- Large Shareholder at Phathom Pharmaceuticals Inc. (PHAT), 2021-03-15
- Large Shareholder, Director at Orchard Therapeutics Plc (ORTX), 2021-02-11
- Large Shareholder at Iterum Therapeutics Plc (ITRM), 2021-02-08
- Large Shareholder at Miragen Therapeutics Inc. (MGEN), 2020-12-17
- Other at Rhythm Pharmaceuticals Inc. (RYTM), 2020-12-04
- Large Shareholder at Vaxcyte Inc. (PCVX), 2020-10-09
- Large Shareholder at Cardiff Oncology Inc. (CRDF), 2020-10-02
- Large Shareholder at Pmv Pharmaceuticals Inc. (PMVP), 2020-09-29
- Large Shareholder at Dyne Therapeutics Inc. (DYN), 2020-09-23
- Large Shareholder at Tg Therapeutics Inc. (TGTX), 2020-09-11
- Large Shareholder at Inhibrx Inc. (INBX), 2020-08-24
- Large Shareholder at Inozyme Pharma Inc. (INZY), 2020-07-28
- Large Shareholder at Pandion Therapeutics Inc. (PAND), 2020-07-22
- Large Shareholder at Akouos Inc. (AKUS), 2020-07-02
- Large Shareholder at Verastem Inc. (VSTM), 2020-06-29
- Large Shareholder, Director at Ra Pharmaceuticals Inc. (RARX), 2020-04-03
- Large Shareholder at Synthorx Inc. (THOR), 2020-01-24
- Large Shareholder at Eiger Biopharmaceuticals Inc. (EIGR), 2018-10-25
- Other at Arvinas Inc. (ARVN), 2018-10-03
- Director at Eidos Therapeutics Inc. (EIDX), 2018-06-22
- Large Shareholder at Dicerna Pharmaceuticals Inc (DRNA), 2017-12-21
- Large Shareholder, Director at Kalvista Pharmaceuticals Inc. (KALV), 2017-10-16
- Other at G1 Therapeutics Inc. (GTHX), 2017-05-24
- Large Shareholder at Aclaris Therapeutics Inc. (ACRS), 2016-09-19
- Other at Sangamo Biosciences Inc (SGMO), 2015-02-19
- Other at Achillion Pharmaceuticals Inc (ACHN), 2015-01-20
- Other at Derma Sciences Inc. (DSCI), 2014-01-13
- Large Shareholder at Biospecifics Technologies Corp (BSTC), 2010-02-26
Insider Trading: Purchases See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
SPRY | $6.20 | 3,750,000 | Director | 5,856,774 | 2023-08-29 | Filing | |
ANTX | $9.00 | 1,777,778 | Large Shareholder | 5,135,683 | 2023-08-18 | Filing | |
ABOS | $7.75 | 5,161,290 | Large Shareholder, Director | 13,043,179 | 2023-07-21 | Filing | |
JANX | $12.46 | 495,008 | Large Shareholder, Director | 8,117,246 | 2023-07-19 | Filing | |
BDTX | $5.00 | 935,850 | Director | 3,213,828 | 2023-07-05 | Filing |
Insider Trading: Sales See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
KALA | $0.36 | 1,005,686 | Large Shareholder | 7,039,613 | 2022-05-26 | Filing | |
KALA | $0.42 | 1,434,509 | Large Shareholder | 8,045,299 | 2022-05-25 | Filing | |
KALA | $0.51 | 144,805 | Large Shareholder | 9,479,808 | 2022-05-24 | Filing | |
KALA | $0.65 | 1,250,000 | Large Shareholder | 9,624,613 | 2022-05-23 | Filing | |
SCPH | $7.03 | 110,588 | Large Shareholder | 2,727,446 | 2021-03-15 | Filing |